Gaëlle S. Kolly

DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization

Miroslav Brecik, Ivana Centárová, Raju Mukherjee et al. · ACS Chemical Biology · 2015 · 162 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

2-Carboxyquinoxalines Kill <i>Mycobacterium tuberculosis</i> through Noncovalent Inhibition of DprE1

João Neres, Ruben C. Hartkoorn, Laurent R. Chiarelli et al. · ACS Chemical Biology · 2014 · 136 citations · Full text

Life Sciences, Microbiology, Molecular Biology +13

Assessing the essentiality of the decaprenyl‐phospho‐<scp>d</scp>‐arabinofuranose pathway in <scp><i>M</i></scp><i>ycobacterium tuberculosis</i> using conditional mutants

Gaëlle S. Kolly, Francesca Boldrin, Claudia Sala et al. · Molecular Microbiology · 2014 · 93 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +10

The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis

Vadim Makarov, João Neres, Ruben C. Hartkoorn et al. · Antimicrobial Agents and Chemotherapy · 2015 · 79 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Massive Gene Duplication Event among Clinical Isolates of the <i>Mycobacterium tuberculosis</i> W/Beijing Family

Pilar Domenech, Gaëlle S. Kolly, Lizbel León-Solís et al. · Journal of Bacteriology · 2010 · 71 citations · Full text

Life Sciences, Genetics, Microbiology +11